Integrated Proteins Ltd (519606)

Integrated Proteins reported standalone revenue from operations of ₹399.60 lakh for the quarter ended September 30, 2026, alongside other income of ₹0.50 lakh, totaling ₹400.10 lakh. Profit after tax for Q2 stood at ₹5.50 lakh, compared to ₹5.04 lakh in the corresponding quarter last year. For the half-year (H1 FY27), total revenue reached ₹1,456.43 lakh with net profit of ₹42.16 lakh. Total expenses for the quarter were ₹392.21 lakh, primarily driven by stock-in-trade purchases of ₹388.51 lakh.

• Q2 revenue from operations stood at ₹399.60 lakh versus ₹419.83 lakh in Q2 FY26
• Net profit after tax for the quarter was ₹5.50 lakh compared to ₹5.04 lakh in Q2 FY26
• Half-year (ended Sep 30, 2026) net profit surged to ₹42.16 lakh on total revenue of ₹1,456.43 lakh
• Operating cash flows for H1 were negative at -₹677.21 lakh, supported by short-term borrowings of ₹388.12 lakh

Integrated Proteins Limited has incorporated a wholly owned subsidiary named Terranexa Agtech Inc. in New Jersey, USA. The authorized and paid-up share capital of the new entity is $1,000 (approx ₹95,000) divided into 1,000 shares of $1 each. The subsidiary will focus on agricultural technology services to leverage growth opportunities in the US market. The transaction is funded entirely via cash consideration for 100% equity control.

• Incorporated wholly owned subsidiary named Terranexa Agtech Inc. in New Jersey, USA
• Authorized and paid-up capital of $1,000 (~₹95,000) divided into 1,000 shares of $1 each
• Acquisition cost is at face value of $1 per share via cash consideration
• Company holds 100% of total capital in the newly formed entity

Integrated Proteins Limited concluded its Annual General Meeting on September 30, 2026, where members approved ordinary business and appointments. Mr. Sandeep Mahadik was regularized as an Independent Director for a 5-year term ending July 8, 2031. Additionally, CS Ankita Shah was appointed as the Secretarial Auditor for FY 2026-2027. The company operates at a modest scale with a market capitalization of Rs 18 Cr and TTM revenue of Rs 11 Cr.

• AGM held and concluded on September 30, 2026, running from 13:00 to 13:22 IST
• Appointment of Sandeep Mahadik as Independent Director for 5 years (July 9, 2026 to July 8, 2031)
• Appointment of CS Ankita Shah as Secretarial Auditor for FY 2026-2027
• Final voting results to be submitted to BSE by October 2, 2026

Integrated Proteins Limited has fixed Friday, September 4, 2026 as the record date for its equity share sub-division. Each existing equity share of face value ₹10 will be split into 10 equity shares of face value ₹1 each. The sub-division was approved by shareholders at the Extraordinary General Meeting held on August 20, 2026.

• Record date fixed for September 4, 2026 for equity share split
• Share sub-division ratio is 1:10 (1 equity share of ₹10 face value into 10 shares of ₹1 face value)
• Shareholder approval secured at the EGM held on August 20, 2026

Integrated Proteins Ltd has scheduled a board meeting for August 14, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. The company is coming off a fiscal year (FY26) with a total revenue of ₹9.94 Cr and a thin net profit of ₹0.23 Cr. Despite a high P/E ratio of 1200.0 and a significant 436.9% price return over the last 6 months, the company's operations remain small-scale with an operating margin of just 2.4%. Investors should be aware of the extremely low promoter holding, which stood at 2.23% as of March 2026.

• Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results.
• Trading window has been closed since July 1, 2026, per SEBI insider trading regulations.
• Company reported a revenue of ₹5.69 Cr in the most recent quarter (March 2026).
• Promoter holding remains low at 2.23% as of the last reporting period.
• Market capitalization stands at ₹264 Cr against a TTM revenue of only ₹10 Cr.

Integrated Proteins Ltd has issued a notice for an Extraordinary General Meeting (EGM) on August 20, 2026, to approve a 1:10 stock split. The proposal involves sub-dividing each equity share of face value ₹10 into 10 shares of face value ₹1 each to improve liquidity. Additionally, the company seeks shareholder approval to regularise the appointments of Mr. Hiren Dhirajlal Shah as Chairman and Managing Director and Mr. Nitish Pratapray Mehta as a Non-Executive Director. This comes amid a period of high stock price volatility, with a 353% return over the last six months despite a small TTM revenue of ₹10 Cr.

• Proposed stock split of 1 equity share (face value ₹10) into 10 equity shares (face value ₹1).
• EGM scheduled for August 20, 2026, at 1:00 PM via Video Conferencing.
• Authorized Share Capital to be reclassified into 25,00,00,000 equity shares of ₹1 each, maintaining the total at ₹25 Cr.
• Regularisation of Mr. Hiren Dhirajlal Shah as CMD following his initial appointment on July 9, 2026.
• Promoter holding remains exceptionally low at 2.23% as of the latest March 2026 filing.

Integrated Proteins Ltd has announced the resignation of Ms. Shivangi Paliwal from the post of Company Secretary and Compliance Officer, effective July 27, 2026. The resignation was accepted during a board meeting held on the same day and is attributed to personal reasons. This change comes at a time when the company has a very low promoter holding of 2.23% and a high P/E ratio of 1198.7. The company must now appoint a successor to ensure continued regulatory compliance.

• Ms. Shivangi Paliwal resigned as Company Secretary and Compliance Officer effective July 27, 2026
• The Board Meeting to approve the resignation lasted 30 minutes, from 17:00 to 17:30 HRS
• The company reported a TTM revenue of Rs 10 Cr against a market capitalization of Rs 264 Cr
• Promoter holding remains low at 2.23% as of March 2026

Integrated Proteins Ltd has approved the redesignation of Mr. Hiren Shah from Additional Executive Director to Chairman and Managing Director (CMD) for a five-year term starting July 24, 2026. This leadership change comes at a time when the company maintains a very small financial scale, with TTM revenue of just ₹10 Cr and a high P/E ratio of 1175.0. The appointment is subject to shareholder approval at an Extra-Ordinary General Meeting (EGM) scheduled for August 20, 2026. Investors should note the significant decline in promoter holding, which stood at 2.23% in March 2026 compared to 13.04% in September 2025.

• Mr. Hiren Shah redesignated as Chairman and Managing Director for a 5-year term ending July 23, 2031
• Extra-Ordinary General Meeting (EGM) to be held on August 20, 2026, via video conferencing
• Cut-off date for e-voting eligibility set for August 13, 2026
• Promoter holding has dropped significantly to 2.23% as of the latest March 2026 filing
• Company reported a TTM revenue of ₹10 Cr with a thin operating margin of 2.4%

Integrated Proteins Ltd has filed an application with BSE for the reclassification of 10 individuals from the 'Promoter and Promoter Group' to the 'Public' category. These individuals collectively hold 4,17,620 shares, representing 2.22% of the company's total equity. Five of the ten individuals currently hold zero shares in the company. This procedural filing follows formal request letters received by the company on July 7, 2026.

• 10 individuals from the Promoter Group have applied for reclassification to the Public category
• Total shares held by the outgoing group amount to 4,17,620 shares or 2.22% of the company
• Vinod Prabhulal Mehta holds the largest stake among the outgoing group at 1.72% (3,22,300 shares)
• 5 out of the 10 individuals seeking reclassification currently hold 0.00% shares
• The application was submitted to BSE on July 14, 2026, following requests dated July 7, 2026